The pharmaceuticals industry’s future success will require a new generation of executives who can find a fresh way to look at the world’s health challenges and its neediest countries, said Tachi Yamada, global health chief of the Bill and Melinda Gates Foundation.

“Pharma was an industry in which it was almost too easy to be successful. It was a licence to print money. In a way, that is how it lost its way.